中国医药：拟5.25亿元收购则正医药70%股权

Group 1 - The core point of the article is that China Medical (600056.SH) announced the acquisition of a 70% stake in Shanghai Zezheng Pharmaceutical Technology Co., Ltd. for a total amount of RMB 525 million [1] - The acquisition was approved during the 34th meeting of the 9th Board of Directors held on December 29, 2025 [1] - Shanghai Zezheng Pharmaceutical, established in 2017, specializes in the research and development of modified new drugs and complex formulations, providing a full range of R&D services including drug research, clinical trials, and registration applications [1]